FindTrial
Sign In

Double j Stent Related Symptoms

Comparison of Mirabegron ,Tamsulosin and Solifenacinin Relieving Double -J Stent Related Symptoms : Approspective Randmized Placebo Controlledtrial

Status
Completed
Phases
Early Phase 1
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07447518
Enrollment
535
Registered
2026-03-03
Start date
2022-09-22
Completion date
2023-09-01
Last updated
2026-03-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Lower Urinary Tract Symptoms

Keywords

LUTS, Double j

Brief summary

In urology, ureteral stents are used to treat obstructive diseases. Hematuria (54%), fever, discomfort, and lower urinary system symptoms are the predominant symptoms related to ureteral stent.

Interventions

DRUGTadalafil 5mg

once daily 5mg

DRUGsolidosin

once daily

DRUGSolfenacin

once dialy

DRUGMirabegron

once daily

DRUGPlacebo

once daily

Sponsors

Kafrelsheikh University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* age above 18 years * any patient need post urs or pcnl double stent

Exclusion criteria

* age less than 18 years * known over active bladder patient

Design outcomes

Primary

MeasureTime frameDescription
Double j related symptomsSix weeksDouble j related symptoms questionnaire score

Secondary

MeasureTime frameDescription
Sex matters related double j stentSix weeksSex matters related stent

Countries

Egypt

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 4, 2026